COVID-19 Silver Lining: Top Tech Talent Takes A Closer Look At Pharma
A survey of 2,500 technology professionals across five countries conducted by Novartis finds technology talent wants to work in health care and pharma more now than before the pandemic.
You may also be interested in...
Industry leaders at a PhRMA briefing talked about the unprecedented level of partnership going into developing COVID-19 vaccines and treatments – not to mention making enough of them.
Novartis has accelerated its digital ambitions during the worldwide lockdown period, working with partners such as Doximity on engaging doctors and Science 37 on virtual trial tech.
The pandemic has reignited interest and investment in vaccines across a wide array of disease areas by big pharma and venture investors, a panel of BIO experts said.